Reuters logo
BRIEF-Zynerba Pharmaceuticals posts Q3 loss per share of $0.67
November 14, 2016 / 12:22 PM / in a year

BRIEF-Zynerba Pharmaceuticals posts Q3 loss per share of $0.67

Nov 14 (Reuters) - Zynerba Pharmaceuticals Inc

* Zynerba Pharma - believes available funds sufficient to develop five phase 3 ready programs, sufficient to fund operations & capital requirements into 2018

* Q3 loss per share $0.67

* Zynerba Pharmaceuticals reports third quarter 2016 financial results and operational highlights

* Q3 earnings per share view $-0.69 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below